Typhoid News and Research

RSS
Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

IVI and Lemonex sign MOU to join forces on vaccine development

IVI and Lemonex sign MOU to join forces on vaccine development

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

Pathogens in ancient DNA could explain how two civilizations collapsed

Pathogens in ancient DNA could explain how two civilizations collapsed

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

Can COVID-19 vaccination cause menstrual bleeding changes?

Can COVID-19 vaccination cause menstrual bleeding changes?

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Drug-resistant typhoid needs to be treated as a global problem

Drug-resistant typhoid needs to be treated as a global problem

Bacteria causing typhoid fever are highly developing antibiotic resistance

Bacteria causing typhoid fever are highly developing antibiotic resistance

Study estimates the global RSV disease burden in children under five in 2019

Study estimates the global RSV disease burden in children under five in 2019

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

Moderate fitness levels produce significantly larger immune response in breast cancer survivors

Moderate fitness levels produce significantly larger immune response in breast cancer survivors

Phase I/II trials of new paratyphoid vaccine begin in Oxford

Phase I/II trials of new paratyphoid vaccine begin in Oxford

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Impact of COVID-19 pandemic on vaccination campaigns for diseases preventable by vaccine

Impact of COVID-19 pandemic on vaccination campaigns for diseases preventable by vaccine

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

Travel in the time of covid: Getting there is easy — It’s getting home that’s hard

Travel in the time of covid: Getting there is easy — It’s getting home that’s hard